MetaCap

Palvella Therapeutics (PVLA) News

NASDAQ: PVLAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

142.85-2.92 (-2.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PVLA news summary

We found 11 recent headlines mentioning Palvella Therapeutics (PVLA): 3 in the past week and 7 in the past 30 days, most often from GlobeNewswire, Nasdaq, Seeking Alpha. For price context, PVLA is down 2.00% at $142.85. The most recent story, "Palvella Therapeutics Announces QTORIN™ Docetaxel, a New QTORIN™ Program for the Treatment of Extramammary Paget’s Disease (EMPD)", was published by GlobeNewswire on Nov 19, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Palvella Therapeutics headlines

Compare PVLA